CA
NZ
UK
AU
IND
US
…
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Bloomios Inc (OTC Pink: BLMS) is limited and available filings do not clearly describe its core operations or strategy, so the company's business model and long-term growth drivers are not well disclosed. Because detailed disclosures are sparse, investors should review recent SEC filings and company communications for clarity; some market participants may be attracted by the potential upside typical of thinly traded microcaps, although that potential is uncertain.
The principal investment risks are extremely limited public disclosure, low trading liquidity, lack of verifiable operating history, potential for dilution and elevated financial and regulatory uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -39.61M | -13.77M | -2.01M | -1.17M | -0.49M |
| Net income | -39.61M | -13.77M | -2.01M | -1.17M | -0.49M |
| Selling general administrative | 6.88M | 5.87M | 4.12M | 1.23M | 0.47M |
| Gross profit | 2.05M | 2.23M | 3.78M | 0.40M | 0.00M |
| Reconciled depreciation | 0.24M | 0.44M | 0.38M | 0.23M | 0.00M |
| Ebit | - | -4.14M | -0.80M | -1.06M | -0.02M |
| Ebitda | - | -12.37M | -1.38M | -0.87M | -0.49M |
| Operating income | -5.02M | -4.08M | -0.72M | -1.06M | -0.47M |
| Interest expense | 2.80M | 0.97M | 0.25M | 0.07M | 0.00M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -9.58M | -7.85M | -1.53M | -0.11M | -0.02M |
| Total revenue | 8.23M | 6.08M | 8.49M | 1.32M | 0.00M |
| Total operating expenses | 13.25M | 10.16M | 9.21M | 2.38M | 0.47M |
| Cost of revenue | 6.18M | 3.85M | 4.71M | 0.91M | 0.00M |
| Total other income expense net | -25.01M | -1.84M | 0.24M | - | - |
| Net income from continuing ops | -39.61M | -13.77M | -2.01M | -1.17M | -0.49M |
| Net income applicable to common shares | - | -13.77M | -2.01M | -1.17M | -0.02M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 26.01M | 4.01M | 3.19M | 0.00M | 0.00M |
| Total liab | 27.33M | 5.58M | 4.46M | 0.47M | 0.00M |
| Total stockholder equity | -1.32M | -1.57M | -1.26M | -0.47M | 0.00M |
| Other current liab | 1.24M | 0.54M | 0.75M | - | - |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 8.50M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -20.11M | -6.34M | -4.32M | -2.68M | -2.66M |
| Good will | 21.87M | 0.30M | 0.30M | 0.00M | - |
| Other assets | 0.12M | 0.12M | 0.11M | - | - |
| Cash | 0.00M | 0.27M | 0.07M | 0.00M | 0.00M |
| Total current liabilities | 27.18M | 5.33M | 3.48M | 0.43M | 0.00M |
| Net debt | 22.42M | 2.08M | 1.54M | 0.04M | - |
| Short long term debt | 22.27M | 2.20M | 0.78M | - | - |
| Other stockholder equity | 3.85M | 0.06M | - | - | - |
| Property plant equipment | 1.58M | 2.08M | 2.33M | - | - |
| Total current assets | 2.44M | 1.51M | 0.45M | 0.00M | 0.00M |
| Long term investments | 0.00M | - | - | - | - |
| Net tangible assets | -31.69M | -1.87M | -1.56M | -0.47M | - |
| Short term investments | - | - | 0.05M | 0.00M | - |
| Net receivables | 0.53M | 0.06M | 0.04M | 0.00M | - |
| Long term debt | 0.15M | 0.15M | 0.83M | 0.04M | - |
| Inventory | 1.77M | 0.51M | 0.29M | 0.00M | - |
| Accounts payable | 2.34M | 2.24M | 1.75M | 0.43M | - |
| Non currrent assets other | 0.07M | 0.07M | 0.06M | - | - |
| Non current assets total | 23.57M | 2.49M | 2.74M | 0.00M | 0.00M |
| Capital lease obligations | 0.06M | 0.21M | 0.26M | 0.00M | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 0.67M | -0.02M | -0.80M | -0.05M | -0.05M |
| Change to liabilities | - | 2.94M | 0.72M | 1.54M | 0.00M |
| Total cashflows from investing activities | - | -0.02M | -0.80M | -2.70M | -2.70M |
| Net borrowings | - | 6.08M | 1.10M | 1.57M | 1.57M |
| Total cash from financing activities | 6.44M | 6.08M | 1.10M | 1.95M | 0.02M |
| Change to operating activities | - | 1.06M | 0.01M | 0.55M | 0.55M |
| Net income | -39.61M | -13.77M | -2.01M | -1.17M | -0.02M |
| Change in cash | -0.08M | -0.34M | 0.20M | 0.07M | 0.07M |
| Begin period cash flow | 0.01M | 0.27M | 0.07M | 0.00M | 0.00M |
| End period cash flow | - | 0.00M | 0.27M | 0.07M | 0.00M |
| Total cash from operating activities | -7.11M | -6.33M | -0.10M | 0.82M | -0.02M |
| Issuance of capital stock | - | - | - | 0.38M | 0.02M |
| Depreciation | 0.24M | 0.44M | 0.38M | 0.23M | 0.23M |
| Other cashflows from investing activities | - | 9.50M | 9.50M | -0.35M | -0.35M |
| Change to inventory | 0.25M | -1.26M | -0.22M | -0.29M | -0.29M |
| Change to account receivables | -0.26M | -0.47M | -0.02M | -0.04M | -0.04M |
| Change to netincome | - | 1.04M | 1.09M | 1.09M | 1.09M |
| Capital expenditures | 0.00M | 0.02M | 0.80M | 2.30M | 2.30M |
| Change in working capital | 9.80M | 2.28M | 0.44M | 1.76M | 0.43M |
| Stock based compensation | -0.40M | 0.53M | 0.28M | - | - |
| Other non cash items | 2.36M | 4.20M | 1.13M | - | - |
| Free cash flow | -7.11M | -6.35M | -0.90M | -1.48M | -0.06M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BLMS Bloomios Inc |
- -% |
0.00 | - | - | 0.00 | - | 4.02 | -0.91 |
| MKKGY Merck KGaA ADR |
-0.50 1.48% |
33.21 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
-1.26 0.75% |
167.45 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
- -% |
20.75 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
-0.91 2.17% |
41.09 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael Hill | CEO & Chairman | 1976 |
| Mr. Barrett Evans | Chief Strategy Officer, Pres, Sec. & Director | 1973 |
| Mr. John Bennett | CFO, Treasurer & Director | 1960 |
| Mr. Barrett Evans | Chief Strategy Officer, President, Secretary & Director | 1973 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.39%
Communication Services
+0.40%
Consumer Cyclical
-0.20%
Consumer Defensive
-0.56%
Energy
-0.45%
Financial Services
-0.09%
Financials
+0.11%
Healthcare
+0.40%
Industrials
+0.34%
Real Estate
-0.14%
Technology
+0.88%
Utilities
+0.11%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...